Lido Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.98M Hold
6,500
0.02% 420
2025
Q4
$6.99M Hold
6,500
0.02% 383
2025
Q3
$4.96M Hold
6,500
0.02% 445
2025
Q2
$5.07M Buy
6,500
+1,700
+35% +$1.32M 0.02% 369
2025
Q1
$3.96M Hold
4,800
0.02% 394
2024
Q4
$3.71M Buy
4,800
+2,300
+92% +$1.9M 0.02% 391
2024
Q3
$2.21M Sell
2,500
-1,600
-39% -$1.44M 0.01% 449
2024
Q2
$3.71M Buy
4,100
+1,600
+64% +$1.28M 0.02% 328
2024
Q1
$1.94M Buy
2,500
+300
+14% +$214K 0.01% 435
2023
Q4
$1.28M Buy
2,200
+600
+38% +$350K 0.01% 528
2023
Q3
$859K Buy
1,600
+500
+45% +$258K 0.01% 586
2023
Q2
$516K Buy
1,100
+700
+175% +$294K ﹤0.01% 727
2023
Q1
$137K Hold
400
﹤0.01% 1058
2022
Q4
$146K Buy
+400
New +$142K ﹤0.01% 937

Other funds holding LLY

Lido Advisors's LLY Position: Q1 2026 in Review

Lido Advisors reduced its Eli Lilly (LLY) stake by 17% in Q1 2026, selling an estimated $22.1M and leaving 108,867 shares worth $100M. The position accounts for 0.31% of the portfolio, ranked #53.

Lido Advisors first reported a position in LLY in Q1 2016 and has held it in 34 quarters since. The position peaked at $113M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Lido Advisors held 108,867 shares of Eli Lilly worth $100M as of Q1 2026.
  • Lido Advisors sold 21,808 Eli Lilly shares in Q1 2026, an estimated $22.1M.
  • Eli Lilly made up 0.31% of Lido Advisors's portfolio in Q1 2026, its #53 holding.
  • Lido Advisors first reported a position in Eli Lilly in Q1 2016 and has held it in 34 quarters since.
  • Lido Advisors's Eli Lilly position peaked at $113M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.